Pediatrix Medical Group reported second-quarter 2026 adjusted earnings per share of 63 cents, beating the Zacks Consensus Estimate by 10.5% and rising 18.9% year over year. Net revenues increased 4.1% to $487.8 million, surpassing estimates by 2.2%, driven by improved cash collection activity and a favorable payor mix, along with contributions from recent acquisitions, though partly offset by lower patient volumes and higher operating costs. Adjusted EBITDA rose 4.4% to $76.4 million, and the company reaffirmed its full-year 2026 adjusted EBITDA guidance of $280 million to $300 million. During the first half of 2026, Pediatrix repurchased 2.8 million shares for $61.7 million, with $104.5 million remaining under its buyback program as of June 30.
Mednax IncPediatrix Medical (Mednax) beat Q2 earnings estimates on improved cash collections and reaffirmed guidance
Elevance Health Inc
Tenet Healthcare Corporation
UnitedHealth Group Incorporated